Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel I Swerdlow

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Lancet. Diabetes & Endocrinology|January 20, 2016
Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysisJon White, Reecha Sofat, Gibran Hemani, et al.
European Heart Journal|January 30, 2014
Mendelian randomization of blood lipids for coronary heart diseaseMichael V Holmes, Folkert W Asselbergs, Tom M Palmer, et al.
Journal of the American College of Cardiology|August 7, 2013
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization studyMichael V Holmes, Tabassome Simon, Holly J Exeter, et al.
Lancet (London, England)|March 17, 2012
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis, Daniel I Swerdlow, Michael V Holmes, et al.
The Lancet. Diabetes & Endocrinology|December 3, 2016
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation studyAmand F Schmidt, Daniel I Swerdlow, Michael V Holmes, et al.
Lancet (London, England)|September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.
Nature Communications|January 11, 2020
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failureSonia Shah, Albert Henry, Carolina Roselli, et al.
BMC Cardiovascular Disorders|October 31, 2019
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9Amand F Schmidt, Michael V Holmes, David Preiss, et al.
BMJ (Clinical Research Ed.)|July 12, 2014
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant dataMichael V Holmes, Caroline E Dale, Luisa Zuccolo, et al.
ESC Heart Failure|September 4, 2021
The genomics of heart failure: design and rationale of the HERMES consortiumR Thomas Lumbers, Sonia Shah, Honghuang Lin, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Lancet. Diabetes & Endocrinology|January 20, 2016
Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysisJon White, Reecha Sofat, Gibran Hemani, et al.
European Heart Journal|January 30, 2014
Mendelian randomization of blood lipids for coronary heart diseaseMichael V Holmes, Folkert W Asselbergs, Tom M Palmer, et al.
Journal of the American College of Cardiology|August 7, 2013
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization studyMichael V Holmes, Tabassome Simon, Holly J Exeter, et al.
Lancet (London, England)|March 17, 2012
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis, Daniel I Swerdlow, Michael V Holmes, et al.
The Lancet. Diabetes & Endocrinology|December 3, 2016
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation studyAmand F Schmidt, Daniel I Swerdlow, Michael V Holmes, et al.
Lancet (London, England)|September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.
Nature Communications|January 11, 2020
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failureSonia Shah, Albert Henry, Carolina Roselli, et al.
BMC Cardiovascular Disorders|October 31, 2019
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9Amand F Schmidt, Michael V Holmes, David Preiss, et al.
BMJ (Clinical Research Ed.)|July 12, 2014
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant dataMichael V Holmes, Caroline E Dale, Luisa Zuccolo, et al.
ESC Heart Failure|September 4, 2021
The genomics of heart failure: design and rationale of the HERMES consortiumR Thomas Lumbers, Sonia Shah, Honghuang Lin, et al.
Pageof 4